Cover Image

Current management of stage IB2 and bulky IIA, locally advanced, and recurrent cervical carcinoma

Karen K. Lo, Anne O. Rodriguez, Janice Ryu, Vijay P. Khatri
  • Karen K. Lo
    Department of Surgery, Division of Surgical Oncology, University of California, Davis, Cancer Center, Sacramento, United States | vijay.khatri@ucdmc.ucdavis.edu
  • Anne O. Rodriguez
    Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University of California, Davis, Sacramento, United States
  • Janice Ryu
    Department of Radiation Oncology, University of California Davis, Sacramento, United States
  • Vijay P. Khatri
    Department of Surgery, Division of Surgical Oncology, University of California, Davis, Cancer Center, Sacramento, United States

Abstract

Cervical cancer is one of the most common cancers affecting women, with most early disease treated with either surgery or radiation alone with an 85%–95% 5-year survival rate, while locally advanced cervical cancer (LACCA) requires multiple therapeutic modalities. The clear distinction between early and LACCA has, in recent years, blurred as stages IB2 and bulky IIA, which were traditionally thought of as early disease, have been shown to require more treatment than other early stage cervical cancer. LACC is now treated with cisplatin-based chemoradiation therapy based upon the results of the randomized co-operative group studies that demonstrated reduced relative risk of death, local failure rates, and incidence of distant metastases. Recurrent cervical cancer is devastating and is rarely cured. Treatment of recurrent cervical carcinoma depends on the previous therapy, the site of recurrence, and the extent of the recurrence. This review will outline the treatment options for the various stages of cervical cancer.

Keywords

Cervical Cancer - Radiation - Chemotherapy - Locally Advanced Cancer - Surgery - Recurrent Disease - Lymph Node Staging

Full Text

FULL TEXT
Submitted: 2011-12-14 23:16:54
Published: 2011-12-14 00:00:00
Search for citations in Google Scholar
Related articles: Google Scholar
Abstract views:
922

Views:
FULL TEXT
128

Article Metrics

Metrics Loading ...

Metrics powered by PLOS ALM


Copyright (c) 2011 Karen K. Lo, Anne O. Rodriguez, Janice Ryu, Vijay P. Khatri

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
 
© PAGEPress 2008-2017     -     PAGEPress is a registered trademark property of PAGEPress srl, Italy.     -     VAT: IT02125780185